Sacubitril is a neprilysin inhibitor used in combination with valsartan to treat chronic heart failure with reduced ejection fraction. As a prodrug, sacubitril is converted to its active metabolite, sacubitrilat,… Read more


![Chemical structure of (2E,4S)-5-[1,1'-Biphenyl]-4-yl-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methyl-2-pentenoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1015037-46-3-2E4S-5-11-Biphenyl-4-yl-4-11-dimethylethoxycarbonylamino-2-methyl-2-pentenoic-Acid.png&w=3840&q=75)


![Chemical structure of (2R,4S)-2-Methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1012341-50-2-2R4S-2-Methyl-4-2-methylpropan-2-yloxycarbonylamino-5-4-phenylphenylpentanoic-Acid.png&w=3840&q=75)

![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-2-methyl-4-nitropentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1982356-32-0-2R4S-5-11-Biphenyl-4-yl-2-methyl-4-nitropentanoic-Acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)(nitroso)amino)-2-methylpentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R4S-5-11-Biphenyl-4-yl-4-tert-butoxycarbonylnitrosoamino-2-methylpentanoic-Acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1-yl)-2-methylpentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1639970-62-9-2R4S-5-11-Biphenyl-4-yl-4-25-dioxopyrrolidin-1-yl-2-methylpentanoic-acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxy-N-nitrosopropanamido)-2-methylpentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R4S-5-11-Biphenyl-4-yl-4-3-carboxy-N-nitrosopropanamido-2-methylpentanoic-Acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F149709-49-9-2R4S-5-11-Biphenyl-4-yl-4-4-ethoxy-4-oxobutanamido-2-methylpentanoic-acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2459446-51-4-2R4S-5-11-Biphenyl-4-yl-4-4-isopropoxy-4-oxobutanamido-2-methylpentanoic-acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-amino-2-methylpentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1039307-95-3-2R4S-5-11-Biphenyl-4-yl-4-amino-2-methylpentanoic-Acid.png&w=3840&q=75)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-amino-2-methylpentanoic Acid Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1038924-71-8-2R4S-5-11-Biphenyl-4-yl-4-amino-2-methylpentanoic-Acid-Hydrochloride.png&w=3840&q=75)
![Chemical structure of (2R,4S)-Isopropyl 5-([1,1'-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2216755-67-6-2R4S-Isopropyl-5-11-biphenyl-4-yl-4-4-isopropoxy-4-oxobutanamido-2-methylpentanoate.png&w=3840&q=75)
![Chemical structure of (2S,4R)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1012341-54-6-2S4R-5-11-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic-Acid.png&w=3840&q=75)


![Chemical structure of (2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1012341-52-4-2S4S-5-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic-Acid.png&w=3840&q=75)



![Chemical structure of (2Z,4R)-5-[1,1′-Biphenyl]-4-yl-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methyl-2-pentenoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1361408-16-3-2Z4R-5-11-Biphenyl-4-yl-4-11-dimethylethoxycarbonylamino-2-methyl-2-pentenoic-Acid.png&w=3840&q=75)

![Chemical structure of (4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2127170-64-1-4S-5-11-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic-Acid.png&w=3840&q=75)

![Chemical structure of (E)-4-((1-([1,1'-Biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopent-3-en-2-yl)amino)-4-oxobutanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FE-4-1-11-Biphenyl-4-yl-5-ethoxy-4-methyl-5-oxopent-3-en-2-ylamino-4-oxobutanoic-Acid.png&w=3840&q=75)
![Chemical structure of (R)-1-(1-([1,1'-Biphenyl]-4-yl)-3-chloropropan-2-yl)pyrrolidine-2,5-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1573000-36-8-R-1-1-11-Biphenyl-4-yl-3-chloropropan-2-ylpyrrolidine-25-dione.png&w=3840&q=75)
![Chemical structure of (R)-1-([1,1'-Biphenyl]-4-yl)-3-(benzyloxy)propan-2-amine Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2024588-68-7-R-1-11-Biphenyl-4-yl-3-benzyloxypropan-2-amine-Hydrochloride.png&w=3840&q=75)
![Chemical structure of (R)-2-(1-([1,1'-Biphenyl]-4-yl)-3-(benzyloxy)propan-2-yl)isoindoline-1,3-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2036308-56-0-R-2-1-11-Biphenyl-4-yl-3-benzyloxypropan-2-ylisoindoline-13-dione.png&w=3840&q=75)


![Chemical structure of (R)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropan-1-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1426129-52-3-R-3-11-Biphenyl-4-yl-2-aminopropan-1-ol.png&w=3840&q=75)
![Chemical structure of (R)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropan-1-ol Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1573000-33-5-R-3-11-Biphenyl-4-yl-2-aminopropan-1-ol-Hydrochloride.png&w=3840&q=75)
![Chemical structure of (R)-4-([1,1'-Biphenyl]-4-ylmethyl)oxazolidin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2829929-67-9-R-4-11-Biphenyl-4-ylmethyloxazolidin-2-one.png&w=3840&q=75)
![Chemical structure of (R)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1426129-50-1-R-tert-Butyl-1-11-biphenyl-4-yl-3-hydroxypropan-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of (R,E)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpent-2-enoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FRE-5-11-Biphenyl-4-yl-4-3-carboxypropanamido-2-methylpent-2-enoic-Acid.png&w=3840&q=75)
![Chemical structure of (R,E)-5-([1,1'-Biphenyl]-4-yl)-4-amino-2-methylpent-2-enoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2459446-56-9-RE-5-11-Biphenyl-4-yl-4-amino-2-methylpent-2-enoic-acid.png&w=3840&q=75)
![Chemical structure of (R,E)-5-([1,1-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1012341-48-8-RE-5-11-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpent-2-enoic-Acid.png&w=3840&q=75)
![Chemical structure of (R,E)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1817838-91-7-RE-Ethyl-5-11-biphenyl-4-yl-4-tert-butoxycarbonylaMino-2-Methylpent-2-enoate.png&w=3840&q=75)
![Chemical structure of (S)-1-(1-([1,1'-Biphenyl]-4-yl)-3-chloropropan-2-yl)pyrrolidine-2,5-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2413471-23-3-S-1-1-11-Biphenyl-4-yl-3-chloropropan-2-ylpyrrolidine-25-dione.png&w=3840&q=75)
![Chemical structure of (S)-1-([1,1'-Biphenyl]-4-yl)-3-(benzyloxy)propan-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1932671-20-9-S-1-11-Biphenyl-4-yl-3-benzyloxypropan-2-ol.png&w=3840&q=75)
![Chemical structure of (S)-5-([1,1'-Biphenyl]-4-ylmethyl)pyrrolidin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1038924-61-6-S-5-11-Biphenyl-4-ylmethylpyrrolidin-2-one.png&w=3840&q=75)
![Chemical structure of (αR,γR)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl-[1,1'-biphenyl]-4-pentanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1012341-56-8-RR-11-Dimethylethoxycarbonylamino-methyl-11-biphenyl-4-pentanoic-Acid.png&w=3840&q=75)

![Chemical structure of 2-Methylpropan-2-aminium (Z)-4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobut-2-enoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Methylpropan-2-aminium-Z-4-2S4R-1-11-biphenyl-4-yl-5-ethoxy-4-methyl-5-oxopentan-2-ylamino-4-oxobut-2-enoate.png&w=3840&q=75)
![Chemical structure of 2-Methylpropan-2-aminium 4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Methylpropan-2-aminium-4-2R4R-1-11-biphenyl-4-yl-5-ethoxy-4-methyl-5-oxopentan-2-ylamino-4-oxobutanoate.png&w=3840&q=75)
![Chemical structure of 2-Methylpropan-2-aminium 4-(((2R,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Methylpropan-2-aminium-4-2R4S-1-11-biphenyl-4-yl-5-ethoxy-4-methyl-5-oxopentan-2-ylamino-4-oxobutanoate.png&w=3840&q=75)
![Chemical structure of 2-Methylpropan-2-aminium 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Methylpropan-2-aminium-4-2S4R-1-11-biphenyl-4-yl-5-methoxy-4-methyl-5-oxopentan-2-ylamino-4-oxobutanoate.png&w=3840&q=75)
Sacubitril is a neprilysin inhibitor used in combination with valsartan to treat chronic heart failure with reduced ejection fraction. As a prodrug, sacubitril is converted to its active metabolite, sacubitrilat, to enhance the effects of natriuretic peptides, helping to reduce cardiac workload and blood pressure. The reference standards for Sacubitril, including its impurities, metabolites, and stable isotope labelled compounds, are critical tools for pharmaceutical laboratories. These materials are essential for conducting rigorous impurity profiling, performing stability-indicating method validation, and ensuring quality control throughout the manufacturing process. By providing high-quality standards that allow for the identification and quantification of synthetic intermediates, process-related by-products, and degradation products, these compounds support regulatory compliance and the maintenance of therapeutic safety. Chemists utilize these reference materials to develop accurate analytical methods, ensuring that every batch meets the stringent requirements for safety and efficacy in clinical applications.